Lai, Tso-Ting <br/><br/>
EFFECT OF REIMBURSEMENT POLICY ON VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH RANIBIZUMAB.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Nov 2020 
 - 2191-2197 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0000000000002716  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Diabetic Retinopathy--drug therapy<br/>Female<br/>Fluorescein Angiography<br/>Health Policy<br/>Humans<br/>Intravitreal Injections<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>National Health Programs<br/>Ranibizumab--therapeutic use<br/>Reimbursement Mechanisms<br/>Retrospective Studies<br/>Subretinal Fluid<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology